Jerrold H Levy Selected Research

Jerrold H Levy Research Topics

Disease

93	Hemorrhage 01/2022 - 06/2003
31	Thrombosis (Thrombus) 01/2022 - 02/2007
26	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2005
25	Sepsis (Septicemia) 06/2022 - 10/2013
21	Disseminated Intravascular Coagulation 01/2022 - 10/2013
19	Inflammation (Inflammations) 06/2022 - 02/2003
17	Wounds and Injuries (Trauma) 01/2021 - 03/2008
16	COVID-19 01/2022 - 01/2020
13	Critical Illness (Critically Ill) 01/2022 - 02/2013
12	Myocardial Infarction 01/2017 - 05/2004
8	Stroke (Strokes) 01/2022 - 09/2005
8	Infections 01/2021 - 10/2018
8	Atrial Fibrillation 01/2020 - 09/2005
5	Shock 06/2022 - 02/2008
5	Venous Thromboembolism 01/2021 - 07/2012
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018 - 09/2014
4	Septic Shock (Toxic Shock Syndrome) 01/2022 - 10/2017
4	Thromboembolism 01/2022 - 01/2020
4	Thrombophilia 12/2020 - 01/2011
4	Anaphylaxis (Anaphylactic Shock) 10/2017 - 06/2004
4	Hypertension (High Blood Pressure) 08/2014 - 05/2002
4	Vascular System Injuries 02/2011 - 06/2006
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 10/2017
3	Pulmonary Embolism 01/2022 - 10/2017
3	Renal Insufficiency (Renal Failure) 01/2020 - 09/2005
3	Left Ventricular Dysfunction 01/2020 - 12/2016
3	Hemophilia A (Haemophilia) 03/2016 - 06/2006
3	Ischemia 02/2016 - 08/2006
3	Hereditary Angioedemas 12/2014 - 01/2004
2	Hypothermia 01/2022 - 01/2020
2	Pain (Aches) 01/2022 - 06/2010
2	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Acidosis 01/2022 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 02/2016
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2021 - 01/2020
2	Hemostatic Disorders 01/2021 - 06/2010
2	Vasculitis (Vasculitides) 12/2020 - 01/2020
2	Necrosis 11/2019 - 02/2011
2	Anemia 03/2019 - 07/2002

Drug/Important Bio-Agent (IBA)

37	AnticoagulantsIBA 01/2022 - 06/2006
30	Hemostatics (Antihemorrhagics)IBA 01/2022 - 09/2005
22	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 07/2005
19	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 10/2018
18	Fibrinogen (Factor I)FDA Link 06/2022 - 01/2004
14	AntithrombinsIBA 12/2021 - 01/2006
12	prothrombin complex concentrates (PPSB)IBA 02/2020 - 11/2008
11	recombinant FVIIa (rFVIIa)FDA Link 03/2016 - 06/2003
10	Thrombin FDA Link 01/2021 - 02/2003
10	Dabigatran FDA Link 11/2017 - 06/2013
8	fibrin fragment D (D-dimer)IBA 06/2022 - 09/2014
7	Factor VIIa (Activated Factor VII)IBA 03/2016 - 01/2006
7	Aprotinin (Trasylol)FDA Link 02/2008 - 01/2004
6	ThrombomodulinIBA 02/2022 - 09/2017
6	Tranexamic Acid (AMCA)FDA Link 01/2022 - 09/2014
6	idarucizumabIBA 05/2017 - 07/2015
5	Thromboplastin (Tissue Factor)IBA 06/2022 - 02/2003
5	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 03/2008
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
5	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021 - 02/2006
5	Vitamin K FDA Link 05/2020 - 05/2016
4	Platelet Factor 4IBA 06/2022 - 02/2007
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2019
4	VaccinesIBA 01/2022 - 07/2021
4	Oxygen (Dioxygen)IBA 01/2022 - 06/2003
4	FibrinIBA 12/2021 - 01/2020
4	Hemoglobins (Hemoglobin)IBA 03/2019 - 05/2011
4	Warfarin (Coumadin)FDA LinkGeneric 05/2016 - 06/2013
4	clevidipine FDA Link 08/2014 - 05/2002
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2013 - 09/2004
4	AntibodiesIBA 12/2012 - 02/2007
4	Complement C5 (Complement 5)IBA 07/2011 - 08/2006
4	pexelizumabIBA 07/2011 - 08/2006
3	von Willebrand FactorIBA 06/2022 - 12/2012
3	EnzymesIBA 01/2022 - 10/2009
3	EndotoxinsIBA 12/2020 - 02/2007
3	Simendan (Levosimendan)IBA 01/2020 - 12/2016
3	CytokinesIBA 01/2020 - 02/2003
3	N(4)-oleylcytosine arabinosideIBA 01/2018 - 09/2014
3	Prasugrel Hydrochloride FDA Link 07/2013 - 07/2012
3	Clopidogrel (Plavix)FDA Link 07/2012 - 08/2004
3	HBOC 201 (Hemopure)IBA 06/2003 - 04/2002
2	ImmunosorbentsIBA 01/2022 - 11/2012
2	Peptides (Polypeptides)IBA 01/2021 - 02/2008
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2020
2	Biological ProductsIBA 01/2020 - 01/2020
2	Fibrin Fibrinogen Degradation ProductsIBA 01/2020 - 09/2017

Therapy/Procedure

43	Therapeutics 12/2021 - 02/2005
20	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022 - 05/2004
13	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2020 - 05/2004
8	Critical Care (Surgical Intensive Care) 01/2021 - 02/2010
5	Extracorporeal Membrane Oxygenation 01/2022 - 05/2013
5	Length of Stay 01/2022 - 08/2004
4	Platelet Transfusion (Blood Platelet Transfusions) 12/2020 - 07/2012
4	Anticoagulation Reversal 05/2017 - 11/2008
4	Off-Label Use 05/2016 - 01/2006
3	Resuscitation 02/2020 - 04/2015
3	Hemodilution 01/2020 - 05/2009
3	Blood Transfusion (Blood Transfusions) 10/2017 - 10/2007